137 related articles for article (PubMed ID: 2753902)
21. A spontaneous mutation of integrin alpha IIb beta 3 (platelet glycoprotein IIb-IIIa) helps define a ligand binding site.
Bajt ML; Ginsberg MH; Frelinger AL; Berndt MC; Loftus JC
J Biol Chem; 1992 Feb; 267(6):3789-94. PubMed ID: 1371279
[TBL] [Abstract][Full Text] [Related]
22. Immobilized Arg-Gly-Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein IIb/IIIa receptor.
Beer JH; Springer KT; Coller BS
Blood; 1992 Jan; 79(1):117-28. PubMed ID: 1728303
[TBL] [Abstract][Full Text] [Related]
23. Determination of the putative binding site for fibronectin on platelet glycoprotein IIb-IIIa complex through a hydropathic complementarity approach.
Pasqualini R; Chamone DF; Brentani RR
J Biol Chem; 1989 Aug; 264(24):14566-70. PubMed ID: 2527238
[TBL] [Abstract][Full Text] [Related]
24. Synthetic peptides demonstrate RGD-independent platelet glycoprotein IIb/IIIa recognition site in cell binding domain of human fibronectin.
Mohri H; Tanabe J; Katoh K; Okubo T
Peptides; 1995; 16(2):263-8. PubMed ID: 7784256
[TBL] [Abstract][Full Text] [Related]
25. Modulation of an RGDS binding site on the platelet membrane glycoprotein IIb-IIIa complex.
Santoro SA; Lawing WJ
Biochem Biophys Res Commun; 1989 Apr; 160(1):189-95. PubMed ID: 2712830
[TBL] [Abstract][Full Text] [Related]
26. Ligands "activate" integrin alpha IIb beta 3 (platelet GPIIb-IIIa).
Du XP; Plow EF; Frelinger AL; O'Toole TE; Loftus JC; Ginsberg MH
Cell; 1991 May; 65(3):409-16. PubMed ID: 2018974
[TBL] [Abstract][Full Text] [Related]
27. Interaction of integrins alpha v beta 3 and glycoprotein IIb-IIIa with fibrinogen. Differential peptide recognition accounts for distinct binding sites.
Smith JW; Ruggeri ZM; Kunicki TJ; Cheresh DA
J Biol Chem; 1990 Jul; 265(21):12267-71. PubMed ID: 2373693
[TBL] [Abstract][Full Text] [Related]
28. Endogenous platelet fibrinogen surface expression on activated platelets.
Gralnick HR; Williams S; McKeown L; Connaghan G; Shafer B; Hansmann K; Vail M; Fenton J
J Lab Clin Med; 1991 Dec; 118(6):604-13. PubMed ID: 1744509
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of action of the antiplatelet peptide, arietin, from Bitis arietans venom.
Huang TF; Wang WJ; Teng CM; Ouyang C
Biochim Biophys Acta; 1991 May; 1074(1):144-50. PubMed ID: 2043664
[TBL] [Abstract][Full Text] [Related]
30. Potent inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Asp-carboxylate of RGDX mimetics and the platelet GP IIb-IIIa receptor.
Zablocki JA; Miyano M; Rao SN; Panzer-Knodle S; Nicholson N; Feigen L
J Med Chem; 1992 Dec; 35(26):4914-7. PubMed ID: 1479591
[No Abstract] [Full Text] [Related]
31. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
[TBL] [Abstract][Full Text] [Related]
32. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.
Bednar RA; Gaul SL; Hamill TG; Egbertson MS; Shafer JA; Hartman GD; Gould RJ; Bednar B
J Pharmacol Exp Ther; 1998 Jun; 285(3):1317-26. PubMed ID: 9618439
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of fibrinogen binding to GP IIb-IIIa by a GP IIIa peptide.
Charo IF; Nannizzi L; Phillips DR; Hsu MA; Scarborough RM
J Biol Chem; 1991 Jan; 266(3):1415-21. PubMed ID: 1703149
[TBL] [Abstract][Full Text] [Related]
34. Localization of the cross-linking sites of RGD and KQAGDV peptides to the isolated fibrinogen receptor, the human platelet integrin glycoprotein IIb/IIIa. Influence of peptide length.
Calvete JJ; Schäfer W; Mann K; Henschen A; González-Rodríguez J
Eur J Biochem; 1992 Jun; 206(3):759-65. PubMed ID: 1376688
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of extra- and intracellular calcium chelation on human platelet function and glycoprotein IIb-IIIa complex stability.
Lanza F; Stierlé A; Gachet C; Cazenave JP
Nouv Rev Fr Hematol (1978); 1992; 34(1):123-31. PubMed ID: 1523093
[TBL] [Abstract][Full Text] [Related]
36. Tetrafibricin, a novel non-peptide fibrinogen receptor antagonist, induces conformational changes in glycoprotein IIb/IIIa.
Satoh T; Kouns WC; Yamashita Y; Kamiyama T; Steiner B
Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):785-91. PubMed ID: 7519850
[TBL] [Abstract][Full Text] [Related]
37. Effect of calcium on the stability of the platelet membrane glycoprotein IIb-IIIa complex.
Brass LF; Shattil SJ; Kunicki TJ; Bennett JS
J Biol Chem; 1985 Jul; 260(13):7875-81. PubMed ID: 2409078
[TBL] [Abstract][Full Text] [Related]
38. Adhesive properties of the beta 3 integrins: comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells.
Kieffer N; Fitzgerald LA; Wolf D; Cheresh DA; Phillips DR
J Cell Biol; 1991 Apr; 113(2):451-61. PubMed ID: 1707057
[TBL] [Abstract][Full Text] [Related]
39. Ligand inhibition of the platelet glycoprotein IIb-IIIa complex function as a calcium channel in liposomes.
Rybak ME; Renzulli LA
J Biol Chem; 1989 Sep; 264(25):14617-20. PubMed ID: 2549026
[TBL] [Abstract][Full Text] [Related]
40. Binding of the snake venom-derived proteins applaggin and echistatin to the arginine-glycine-aspartic acid recognition site(s) on platelet glycoprotein IIb.IIIa complex inhibits receptor function.
Savage B; Marzec UM; Chao BH; Harker LA; Maraganore JM; Ruggeri ZM
J Biol Chem; 1990 Jul; 265(20):11766-72. PubMed ID: 2365698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
